Pharmaceutical industry is expecting M & A boom to be created in earnest with Dream Pharma acquisition as a momentum

On July 3, Dream Pharma selected U.S. pharmaceutical company Alvogen as a preferred bidder of acquisition. Pharmaceutical industry is expecting M & A boom to be created in earnest with this acquisition as a momentum.

Meanwhile, it was estimated that the synergistic effect in accordance with mergers and acquisitions have been minimal because generic drugs were domestic pharmaceutical companies'...